Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carrie A Simpson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2013
In vivo testing for gold nanoparticle toxicityCarrie A Simpson, Brian J Huffman, David E Cliffel
Chemical Research in Toxicology|August 19, 2010
Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactionsCarrie A Simpson, Brian J Huffman, Aren E Gerdon, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 10, 2012
In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticlesCarrie A Simpson, Kenneth J Salleng, David E Cliffel, et al.
ACS Nano|April 9, 2011
Short-chain PEG mixed monolayer protected gold clusters increase clearance and red blood cell countsCarrie A Simpson, Amanda C Agrawal, Andrzej Balinski, et al.
ACS Nano|April 23, 2013
Gastrointestinal bioavailability of 2.0 nm diameter gold nanoparticlesCandice A Smith, Carrie A Simpson, Ganghyeok Kim, et al.
Inorganic Chemistry|November 12, 2010
Tiopronin gold nanoparticle precursor forms aurophilic ring tetramerCarrie A Simpson, Christopher L Farrow, Peng Tian, et al.
Methods in Enzymology|November 7, 2021
Manufacturing plant-made monoclonal antibodies for research or therapeutic applicationsKelsi Swope, Josh Morton, Gregory P Pogue, et al.
Analytical Chemistry|October 26, 2010
A structural mass spectrometry strategy for the relative quantitation of ligands on mixed monolayer-protected gold nanoparticlesKellen M Harkness, Brian C Hixson, Larissa S Fenn, et al.
Vaccines|November 27, 2021
CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated ImmunopathologyJennifer K DeMarco, Joshua M Royal, William E Severson, et al.
Future Medicinal Chemistry|July 2, 2015
Gold nanoparticles to improve HIV drug deliveryCarolina Garrido, Carrie A Simpson, Noelle P Dahl, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2013
In vivo testing for gold nanoparticle toxicityCarrie A Simpson, Brian J Huffman, David E Cliffel
Chemical Research in Toxicology|August 19, 2010
Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactionsCarrie A Simpson, Brian J Huffman, Aren E Gerdon, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 10, 2012
In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticlesCarrie A Simpson, Kenneth J Salleng, David E Cliffel, et al.
ACS Nano|April 9, 2011
Short-chain PEG mixed monolayer protected gold clusters increase clearance and red blood cell countsCarrie A Simpson, Amanda C Agrawal, Andrzej Balinski, et al.
ACS Nano|April 23, 2013
Gastrointestinal bioavailability of 2.0 nm diameter gold nanoparticlesCandice A Smith, Carrie A Simpson, Ganghyeok Kim, et al.
Inorganic Chemistry|November 12, 2010
Tiopronin gold nanoparticle precursor forms aurophilic ring tetramerCarrie A Simpson, Christopher L Farrow, Peng Tian, et al.
Methods in Enzymology|November 7, 2021
Manufacturing plant-made monoclonal antibodies for research or therapeutic applicationsKelsi Swope, Josh Morton, Gregory P Pogue, et al.
Analytical Chemistry|October 26, 2010
A structural mass spectrometry strategy for the relative quantitation of ligands on mixed monolayer-protected gold nanoparticlesKellen M Harkness, Brian C Hixson, Larissa S Fenn, et al.
Vaccines|November 27, 2021
CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated ImmunopathologyJennifer K DeMarco, Joshua M Royal, William E Severson, et al.
Future Medicinal Chemistry|July 2, 2015
Gold nanoparticles to improve HIV drug deliveryCarolina Garrido, Carrie A Simpson, Noelle P Dahl, et al.
Pageof 2